Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Tuberculosis & HIV

Significant Declines in TB Incidence, Prevalence and Mortality, but MDR-TB Remains a Threat

Editor's pick
Global Fund Observer
9 April 2013
Finance & funding

Diagnostic Review of Grants to Guatemala Identifies Both Good Practices and Risks

Editor's pick
Global Fund Observer
29 March 2013
Finance & funding

Government of Azerbaijan Increases Funding for HIV, TB and Malaria as Several Donors Pull Out

Editor's pick
Global Fund Observer
29 March 2013
Activism & civil society

New TB Activist Organisation Launched

Editor's pick
Global Fund Observer
28 March 2013
Government, leadership & policy

Strong leadership, late diagnoses: new ECDC reports show Europe’s response to HIV

Editor's pick
ECDC
28 May 2013
Men who have sex with men (MSM)

ECDC technical report: EMIS 2010, the European Men-Who-Have-Sex-With-Men Internet Survey

Editor's pick
ECDC
28 May 2013
Elimination of hepatitis C

NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

Editor's pick
pharmaphorum
30 April 2019
Elimination of hepatitis C

England hits WHO 2020 hepatitis C target three years early

Editor's pick
The Pharmaceutical Journal
18 April 2019
Elimination of hepatitis C

Health expert says hepatitis C could be eliminated quickly in Scotland

Editor's pick
BBC News
12 April 2019
Hepatitis C treatment

Armenia gets license to produce drugs for hepatitis C treatment

Editor's pick
Public Radio of Armenia
3 April 2019
Hepatitis B

Demand for Hepatitis B Vaccines to Soar from End-use Industries and Push Revenues in the Global Market

Editor's pick
New Daily Herald
2 April 2019
Elimination of hepatitis C

San Francisco Study Shows Engagement in HCV Care Aids Elimination

Editor's pick
Infectious Disease Advisor
2 April 2019
Hepatitis C treatment

Louisiana picks drug company for hepatitis C treatment plan

Editor's pick
San Francisco Chronicle
27 March 2019
Access to healthcare

Interview With Charles Gore, Medicines Patent Pool Executive Director

Editor's pick
Intellectual Property Watch
24 March 2019
Hepatitis B

Hepatitis B Virus Elevates Risk for Age-Related Macular Degeneration

Editor's pick
MD Magazine
14 March 2019
Organ transplants

'Patient No. 1' from a Hep C heart transplant study shares his story

Editor's pick
Cardiovascular Business
8 March 2019
Pharmaceutical industry

Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024

Editor's pick
Honest Businessman
4 March 2019
Finance & funding

A new way to pay for innovative drugs, provide universal access and not break the bank

Editor's pick
The Conversation
28 February 2019
Elimination of hepatitis C

India: National action plan for free treatment of hepatitis patients launched

Editor's pick
The Hindu
27 February 2019
Side effects

Tenofovir Alafenamide Linked to Fanconi Syndrome

Editor's pick
Infectious Disease Advisor
12 February 2019
Exposure to HIV through medical procedures

China says tests on plasma products negative for HIV

Editor's pick
The Associated Press
7 February 2019
Hepatitis C treatment

Hepatitis C Fight Hinges on Prisons

Editor's pick
U.S. News & World Report
5 February 2019
Pharmaceutical industry

The Economics Of Cures - Gilead At A Turning Point

Editor's pick
Seeking Alpha
28 January 2019
Hepatitis C symptoms & diagnosis

Hepatitis C Prevalent in Less Than 1% of US Population

Editor's pick
MD Magazine
18 January 2019